awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36673751-C8CC8773-B354-465B-9E90-0857B4D0E7B0
Q36673751-C8CC8773-B354-465B-9E90-0857B4D0E7B0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36673751-C8CC8773-B354-465B-9E90-0857B4D0E7B0
Afatinib: emerging next-generation tyrosine kinase inhibitor for NSCLC.
P2860
Q36673751-C8CC8773-B354-465B-9E90-0857B4D0E7B0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36673751-C8CC8773-B354-465B-9E90-0857B4D0E7B0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
80ea7c2cf7e7344ab33e97426c8f36d9e11982d8
P2860
A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab